FDA inspection
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site): FDA inspection ending Dec 13, 2013
FDA inspection 865961 · Voluntary Action Indicated (VAI) · Hanzhong
Key facts
| Inspection ID | 865961 |
|---|---|
| Firm | Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site) |
| FEI number | 3003011617 |
| Address | Hanzhong Hi-tech Industries Development Zone, 3 Lianhua Road |
| City | Hanzhong |
| Country | China |
| Fiscal year | 2014 |
| Inspection end date | Dec 13, 2013 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data